Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1999 Dec;81(7):1099–1102. doi: 10.1038/sj.bjc.6690814

BRCA1, BRCA2 and their possible function in DNA damage response

Z Kote-Jarai 1, R A Eeles 1
PMCID: PMC2374315  PMID: 10584867

Full Text

The Full Text of this article is available as a PDF (52.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abbott D. W., Freeman M. L., Holt J. T. Double-strand break repair deficiency and radiation sensitivity in BRCA2 mutant cancer cells. J Natl Cancer Inst. 1998 Jul 1;90(13):978–985. doi: 10.1093/jnci/90.13.978. [DOI] [PubMed] [Google Scholar]
  2. Anderson S. F., Schlegel B. P., Nakajima T., Wolpin E. S., Parvin J. D. BRCA1 protein is linked to the RNA polymerase II holoenzyme complex via RNA helicase A. Nat Genet. 1998 Jul;19(3):254–256. doi: 10.1038/930. [DOI] [PubMed] [Google Scholar]
  3. Andres J. L., Fan S., Turkel G. J., Wang J. A., Twu N. F., Yuan R. Q., Lamszus K., Goldberg I. D., Rosen E. M. Regulation of BRCA1 and BRCA2 expression in human breast cancer cells by DNA-damaging agents. Oncogene. 1998 Apr 30;16(17):2229–2241. doi: 10.1038/sj.onc.1201752. [DOI] [PubMed] [Google Scholar]
  4. Blackshear P. E., Goldsworthy S. M., Foley J. F., McAllister K. A., Bennett L. M., Collins N. K., Bunch D. O., Brown P., Wiseman R. W., Davis B. J. Brca1 and Brca2 expression patterns in mitotic and meiotic cells of mice. Oncogene. 1998 Jan 8;16(1):61–68. doi: 10.1038/sj.onc.1201506. [DOI] [PubMed] [Google Scholar]
  5. Bork P., Hofmann K., Bucher P., Neuwald A. F., Altschul S. F., Koonin E. V. A superfamily of conserved domains in DNA damage-responsive cell cycle checkpoint proteins. FASEB J. 1997 Jan;11(1):68–76. [PubMed] [Google Scholar]
  6. Callebaut I., Mornon J. P. From BRCA1 to RAP1: a widespread BRCT module closely associated with DNA repair. FEBS Lett. 1997 Jan 2;400(1):25–30. doi: 10.1016/s0014-5793(96)01312-9. [DOI] [PubMed] [Google Scholar]
  7. Chapman M. S., Verma I. M. Transcriptional activation by BRCA1. Nature. 1996 Aug 22;382(6593):678–679. doi: 10.1038/382678a0. [DOI] [PubMed] [Google Scholar]
  8. Chen J., Silver D. P., Walpita D., Cantor S. B., Gazdar A. F., Tomlinson G., Couch F. J., Weber B. L., Ashley T., Livingston D. M. Stable interaction between the products of the BRCA1 and BRCA2 tumor suppressor genes in mitotic and meiotic cells. Mol Cell. 1998 Sep;2(3):317–328. doi: 10.1016/s1097-2765(00)80276-2. [DOI] [PubMed] [Google Scholar]
  9. Chen P. L., Chen C. F., Chen Y., Xiao J., Sharp Z. D., Lee W. H. The BRC repeats in BRCA2 are critical for RAD51 binding and resistance to methyl methanesulfonate treatment. Proc Natl Acad Sci U S A. 1998 Apr 28;95(9):5287–5292. doi: 10.1073/pnas.95.9.5287. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Collins N., McManus R., Wooster R., Mangion J., Seal S., Lakhani S. R., Ormiston W., Daly P. A., Ford D., Easton D. F. Consistent loss of the wild type allele in breast cancers from a family linked to the BRCA2 gene on chromosome 13q12-13. Oncogene. 1995 Apr 20;10(8):1673–1675. [PubMed] [Google Scholar]
  11. Devary Y., Rosette C., DiDonato J. A., Karin M. NF-kappa B activation by ultraviolet light not dependent on a nuclear signal. Science. 1993 Sep 10;261(5127):1442–1445. doi: 10.1126/science.8367725. [DOI] [PubMed] [Google Scholar]
  12. Fuks F., Milner J., Kouzarides T. BRCA2 associates with acetyltransferase activity when bound to P/CAF. Oncogene. 1998 Nov 12;17(19):2531–2534. doi: 10.1038/sj.onc.1202475. [DOI] [PubMed] [Google Scholar]
  13. Gowen L. C., Johnson B. L., Latour A. M., Sulik K. K., Koller B. H. Brca1 deficiency results in early embryonic lethality characterized by neuroepithelial abnormalities. Nat Genet. 1996 Feb;12(2):191–194. doi: 10.1038/ng0296-191. [DOI] [PubMed] [Google Scholar]
  14. Gudas J. M., Li T., Nguyen H., Jensen D., Rauscher F. J., 3rd, Cowan K. H. Cell cycle regulation of BRCA1 messenger RNA in human breast epithelial cells. Cell Growth Differ. 1996 Jun;7(6):717–723. [PubMed] [Google Scholar]
  15. Harkin D. P., Bean J. M., Miklos D., Song Y. H., Truong V. B., Englert C., Christians F. C., Ellisen L. W., Maheswaran S., Oliner J. D. Induction of GADD45 and JNK/SAPK-dependent apoptosis following inducible expression of BRCA1. Cell. 1999 May 28;97(5):575–586. doi: 10.1016/s0092-8674(00)80769-2. [DOI] [PubMed] [Google Scholar]
  16. Humphrey J. S., Salim A., Erdos M. R., Collins F. S., Brody L. C., Klausner R. D. Human BRCA1 inhibits growth in yeast: potential use in diagnostic testing. Proc Natl Acad Sci U S A. 1997 May 27;94(11):5820–5825. doi: 10.1073/pnas.94.11.5820. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Jensen D. E., Proctor M., Marquis S. T., Gardner H. P., Ha S. I., Chodosh L. A., Ishov A. M., Tommerup N., Vissing H., Sekido Y. BAP1: a novel ubiquitin hydrolase which binds to the BRCA1 RING finger and enhances BRCA1-mediated cell growth suppression. Oncogene. 1998 Mar 5;16(9):1097–1112. doi: 10.1038/sj.onc.1201861. [DOI] [PubMed] [Google Scholar]
  18. Ludwig T., Chapman D. L., Papaioannou V. E., Efstratiadis A. Targeted mutations of breast cancer susceptibility gene homologs in mice: lethal phenotypes of Brca1, Brca2, Brca1/Brca2, Brca1/p53, and Brca2/p53 nullizygous embryos. Genes Dev. 1997 May 15;11(10):1226–1241. doi: 10.1101/gad.11.10.1226. [DOI] [PubMed] [Google Scholar]
  19. Marcus J. N., Watson P., Page D. L., Narod S. A., Lenoir G. M., Tonin P., Linder-Stephenson L., Salerno G., Conway T. A., Lynch H. T. Hereditary breast cancer: pathobiology, prognosis, and BRCA1 and BRCA2 gene linkage. Cancer. 1996 Feb 15;77(4):697–709. doi: 10.1002/(sici)1097-0142(19960215)77:4<697::aid-cncr16>3.0.co;2-w. [DOI] [PubMed] [Google Scholar]
  20. Marks J. R., Huper G., Vaughn J. P., Davis P. L., Norris J., McDonnell D. P., Wiseman R. W., Futreal P. A., Iglehart J. D. BRCA1 expression is not directly responsive to estrogen. Oncogene. 1997 Jan 9;14(1):115–121. doi: 10.1038/sj.onc.1200808. [DOI] [PubMed] [Google Scholar]
  21. Marmorstein L. Y., Ouchi T., Aaronson S. A. The BRCA2 gene product functionally interacts with p53 and RAD51. Proc Natl Acad Sci U S A. 1998 Nov 10;95(23):13869–13874. doi: 10.1073/pnas.95.23.13869. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Mazoyer S., Puget N., Perrin-Vidoz L., Lynch H. T., Serova-Sinilnikova O. M., Lenoir G. M. A BRCA1 nonsense mutation causes exon skipping. Am J Hum Genet. 1998 Mar;62(3):713–715. doi: 10.1086/301768. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Miki Y., Swensen J., Shattuck-Eidens D., Futreal P. A., Harshman K., Tavtigian S., Liu Q., Cochran C., Bennett L. M., Ding W. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science. 1994 Oct 7;266(5182):66–71. doi: 10.1126/science.7545954. [DOI] [PubMed] [Google Scholar]
  24. Milner J., Ponder B., Hughes-Davies L., Seltmann M., Kouzarides T. Transcriptional activation functions in BRCA2. Nature. 1997 Apr 24;386(6627):772–773. doi: 10.1038/386772a0. [DOI] [PubMed] [Google Scholar]
  25. Monteiro A. N., August A., Hanafusa H. Evidence for a transcriptional activation function of BRCA1 C-terminal region. Proc Natl Acad Sci U S A. 1996 Nov 26;93(24):13595–13599. doi: 10.1073/pnas.93.24.13595. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Nelson W. G., Kastan M. B. DNA strand breaks: the DNA template alterations that trigger p53-dependent DNA damage response pathways. Mol Cell Biol. 1994 Mar;14(3):1815–1823. doi: 10.1128/mcb.14.3.1815. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Neuhausen S. L., Marshall C. J. Loss of heterozygosity in familial tumors from three BRCA1-linked kindreds. Cancer Res. 1994 Dec 1;54(23):6069–6072. [PubMed] [Google Scholar]
  28. Patel K. J., Yu V. P., Lee H., Corcoran A., Thistlethwaite F. C., Evans M. J., Colledge W. H., Friedman L. S., Ponder B. A., Venkitaraman A. R. Involvement of Brca2 in DNA repair. Mol Cell. 1998 Feb;1(3):347–357. doi: 10.1016/s1097-2765(00)80035-0. [DOI] [PubMed] [Google Scholar]
  29. Rajan J. V., Wang M., Marquis S. T., Chodosh L. A. Brca2 is coordinately regulated with Brca1 during proliferation and differentiation in mammary epithelial cells. Proc Natl Acad Sci U S A. 1996 Nov 12;93(23):13078–13083. doi: 10.1073/pnas.93.23.13078. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Scully R., Anderson S. F., Chao D. M., Wei W., Ye L., Young R. A., Livingston D. M., Parvin J. D. BRCA1 is a component of the RNA polymerase II holoenzyme. Proc Natl Acad Sci U S A. 1997 May 27;94(11):5605–5610. doi: 10.1073/pnas.94.11.5605. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Scully R., Chen J., Ochs R. L., Keegan K., Hoekstra M., Feunteun J., Livingston D. M. Dynamic changes of BRCA1 subnuclear location and phosphorylation state are initiated by DNA damage. Cell. 1997 Aug 8;90(3):425–435. doi: 10.1016/s0092-8674(00)80503-6. [DOI] [PubMed] [Google Scholar]
  32. Scully R., Chen J., Plug A., Xiao Y., Weaver D., Feunteun J., Ashley T., Livingston D. M. Association of BRCA1 with Rad51 in mitotic and meiotic cells. Cell. 1997 Jan 24;88(2):265–275. doi: 10.1016/s0092-8674(00)81847-4. [DOI] [PubMed] [Google Scholar]
  33. Sharan S. K., Morimatsu M., Albrecht U., Lim D. S., Regel E., Dinh C., Sands A., Eichele G., Hasty P., Bradley A. Embryonic lethality and radiation hypersensitivity mediated by Rad51 in mice lacking Brca2. Nature. 1997 Apr 24;386(6627):804–810. doi: 10.1038/386804a0. [DOI] [PubMed] [Google Scholar]
  34. Siddique H., Zou J. P., Rao V. N., Reddy E. S. The BRCA2 is a histone acetyltransferase. Oncogene. 1998 Apr 30;16(17):2283–2285. doi: 10.1038/sj.onc.1202003. [DOI] [PubMed] [Google Scholar]
  35. Somasundaram K., Zhang H., Zeng Y. X., Houvras Y., Peng Y., Zhang H., Wu G. S., Licht J. D., Weber B. L., El-Deiry W. S. Arrest of the cell cycle by the tumour-suppressor BRCA1 requires the CDK-inhibitor p21WAF1/CiP1. Nature. 1997 Sep 11;389(6647):187–190. doi: 10.1038/38291. [DOI] [PubMed] [Google Scholar]
  36. Suzuki A., de la Pompa J. L., Hakem R., Elia A., Yoshida R., Mo R., Nishina H., Chuang T., Wakeham A., Itie A. Brca2 is required for embryonic cellular proliferation in the mouse. Genes Dev. 1997 May 15;11(10):1242–1252. doi: 10.1101/gad.11.10.1242. [DOI] [PubMed] [Google Scholar]
  37. Thakur S., Zhang H. B., Peng Y., Le H., Carroll B., Ward T., Yao J., Farid L. M., Couch F. J., Wilson R. B. Localization of BRCA1 and a splice variant identifies the nuclear localization signal. Mol Cell Biol. 1997 Jan;17(1):444–452. doi: 10.1128/mcb.17.1.444. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Vaughn J. P., Davis P. L., Jarboe M. D., Huper G., Evans A. C., Wiseman R. W., Berchuck A., Iglehart J. D., Futreal P. A., Marks J. R. BRCA1 expression is induced before DNA synthesis in both normal and tumor-derived breast cells. Cell Growth Differ. 1996 Jun;7(6):711–715. [PubMed] [Google Scholar]
  39. Wang Q., Zhang H., Kajino K., Greene M. I. BRCA1 binds c-Myc and inhibits its transcriptional and transforming activity in cells. Oncogene. 1998 Oct 15;17(15):1939–1948. doi: 10.1038/sj.onc.1202403. [DOI] [PubMed] [Google Scholar]
  40. Wong A. K., Pero R., Ormonde P. A., Tavtigian S. V., Bartel P. L. RAD51 interacts with the evolutionarily conserved BRC motifs in the human breast cancer susceptibility gene brca2. J Biol Chem. 1997 Dec 19;272(51):31941–31944. doi: 10.1074/jbc.272.51.31941. [DOI] [PubMed] [Google Scholar]
  41. Wooster R., Bignell G., Lancaster J., Swift S., Seal S., Mangion J., Collins N., Gregory S., Gumbs C., Micklem G. Identification of the breast cancer susceptibility gene BRCA2. Nature. 1995 Dec 21;378(6559):789–792. doi: 10.1038/378789a0. [DOI] [PubMed] [Google Scholar]
  42. Zhang H., Somasundaram K., Peng Y., Tian H., Zhang H., Bi D., Weber B. L., El-Deiry W. S. BRCA1 physically associates with p53 and stimulates its transcriptional activity. Oncogene. 1998 Apr 2;16(13):1713–1721. doi: 10.1038/sj.onc.1201932. [DOI] [PubMed] [Google Scholar]
  43. Zhang H., Tombline G., Weber B. L. BRCA1, BRCA2, and DNA damage response: collision or collusion? Cell. 1998 Feb 20;92(4):433–436. doi: 10.1016/s0092-8674(00)80936-8. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES